Xilio Therapeutics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Xilio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $0.00.
- Xilio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $2.02M, a 53.18% decline year-over-year.
- Xilio Therapeutics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $4.31M.
- Xilio Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2025 was $2.02M, a 70.45% decline from fiscal 2024.
- Xilio Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2024 was $6.83M.
- Xilio Therapeutics, Inc. stock issued during period, value, new issues for fiscal 2021 was $116.36M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $2.02M 10-K · filed 2026-03-23 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | |
| 2025-03-31 | $2.02M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $6.83M 10-K · filed 2025-03-11 | |
| 2024-03-31 | $4.31M 10-Q · filed 2024-05-14 | |
| 2021-12-31 | $116.36M 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |